vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and loanDepot, Inc. (LDI). Click either name above to swap in a different company.
loanDepot, Inc. is the larger business by last-quarter revenue ($310.3M vs $270.8M, roughly 1.1× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -7.2%, a 8.0% gap on every dollar of revenue. On growth, loanDepot, Inc. posted the faster year-over-year revenue change (20.5% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-648.0M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
LoanDepot, sometimes stylized as loanDepot, is an Irvine, California-based nonbank holding company which sells mortgage and non-mortgage lending products.
HCM vs LDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $310.3M |
| Net Profit | $2.0M | $-22.5M |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | -10.3% |
| Net Margin | 0.7% | -7.2% |
| Revenue YoY | -16.5% | 20.5% |
| Net Profit YoY | -83.6% | 32.4% |
| EPS (diluted) | $0.00 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $310.3M | ||
| Q3 25 | — | $323.3M | ||
| Q2 25 | $277.7M | $282.5M | ||
| Q1 25 | $324.5M | $273.6M | ||
| Q4 24 | — | $257.5M | ||
| Q3 24 | — | $314.6M | ||
| Q2 24 | $305.7M | $265.4M | ||
| Q1 24 | — | $222.8M |
| Q4 25 | $2.0M | $-22.5M | ||
| Q3 25 | — | $-4.9M | ||
| Q2 25 | $455.0M | $-13.4M | ||
| Q1 25 | $11.9M | $-21.9M | ||
| Q4 24 | — | $-33.2M | ||
| Q3 24 | — | $1.4M | ||
| Q2 24 | $25.8M | $-32.2M | ||
| Q1 24 | — | $-34.3M |
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | -13.2% | -10.3% | ||
| Q3 25 | — | -3.2% | ||
| Q2 25 | -1.3% | -11.4% | ||
| Q1 25 | -5.0% | -16.8% | ||
| Q4 24 | — | -32.7% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | -9.0% | -29.1% | ||
| Q1 24 | — | -38.2% |
| Q4 25 | 0.7% | -7.2% | ||
| Q3 25 | — | -1.5% | ||
| Q2 25 | 163.8% | -4.7% | ||
| Q1 25 | 3.7% | -8.0% | ||
| Q4 24 | — | -12.9% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | 8.4% | -12.1% | ||
| Q1 24 | — | -15.4% |
| Q4 25 | $0.00 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.01 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0.01 | ||
| Q2 24 | $0.03 | $-0.18 | ||
| Q1 24 | — | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $337.2M |
| Total DebtLower is stronger | $93.2M | $2.1B |
| Stockholders' EquityBook value | $1.2B | $386.0M |
| Total Assets | $1.8B | $6.9B |
| Debt / EquityLower = less leverage | 0.08× | 5.44× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $337.2M | ||
| Q3 25 | — | $459.2M | ||
| Q2 25 | $1.4B | $408.6M | ||
| Q1 25 | $836.1M | $371.5M | ||
| Q4 24 | — | $421.6M | ||
| Q3 24 | — | $483.0M | ||
| Q2 24 | $802.5M | $533.2M | ||
| Q1 24 | — | $603.7M |
| Q4 25 | $93.2M | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | $93.4M | $2.1B | ||
| Q1 25 | $82.8M | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $82.1M | $2.0B | ||
| Q1 24 | — | $2.3B |
| Q4 25 | $1.2B | $386.0M | ||
| Q3 25 | — | $433.3M | ||
| Q2 25 | $1.2B | $439.1M | ||
| Q1 25 | $759.9M | $469.3M | ||
| Q4 24 | — | $506.6M | ||
| Q3 24 | — | $592.0M | ||
| Q2 24 | $740.1M | $578.9M | ||
| Q1 24 | — | $637.3M |
| Q4 25 | $1.8B | $6.9B | ||
| Q3 25 | — | $6.2B | ||
| Q2 25 | $1.8B | $6.2B | ||
| Q1 25 | $1.3B | $6.4B | ||
| Q4 24 | — | $6.3B | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | $1.3B | $5.9B | ||
| Q1 24 | — | $6.2B |
| Q4 25 | 0.08× | 5.44× | ||
| Q3 25 | — | 4.83× | ||
| Q2 25 | 0.08× | 4.70× | ||
| Q1 25 | 0.11× | 4.30× | ||
| Q4 24 | — | 4.00× | ||
| Q3 24 | — | 3.31× | ||
| Q2 24 | 0.11× | 3.41× | ||
| Q1 24 | — | 3.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $-638.7M |
| Free Cash FlowOCF − Capex | $3.4M | $-648.0M |
| FCF MarginFCF / Revenue | 1.2% | -208.9% |
| Capex IntensityCapex / Revenue | 1.8% | 3.0% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $-734.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $-638.7M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | $-72.9M | $67.6M | ||
| Q1 25 | $40.3M | $-179.9M | ||
| Q4 24 | — | $47.7M | ||
| Q3 24 | — | $-349.2M | ||
| Q2 24 | $-39.8M | $-278.3M | ||
| Q1 24 | — | $-278.5M |
| Q4 25 | $3.4M | $-648.0M | ||
| Q3 25 | — | $38.7M | ||
| Q2 25 | $-82.2M | $61.4M | ||
| Q1 25 | $32.5M | $-186.7M | ||
| Q4 24 | — | $40.8M | ||
| Q3 24 | — | $-356.4M | ||
| Q2 24 | $-49.9M | $-285.7M | ||
| Q1 24 | — | $-283.3M |
| Q4 25 | 1.2% | -208.9% | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | -29.6% | 21.7% | ||
| Q1 25 | 10.0% | -68.2% | ||
| Q4 24 | — | 15.8% | ||
| Q3 24 | — | -113.3% | ||
| Q2 24 | -16.3% | -107.7% | ||
| Q1 24 | — | -127.2% |
| Q4 25 | 1.8% | 3.0% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | 3.3% | 2.2% | ||
| Q1 25 | 2.4% | 2.5% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | 3.3% | 2.8% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -255.05× | ||
| Q2 24 | -1.54× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
